![Altum sequencing – Following the genetic trail of cancer – Altum sequencing is a biomedical company specializing in the identification of patient specific genetic markers suitable for MRD monitoring. Altum sequencing – Following the genetic trail of cancer – Altum sequencing is a biomedical company specializing in the identification of patient specific genetic markers suitable for MRD monitoring.](https://www.altumsequencing.com/wp-content/uploads/2019/06/Altum-web-color.png)
Altum sequencing – Following the genetic trail of cancer – Altum sequencing is a biomedical company specializing in the identification of patient specific genetic markers suitable for MRD monitoring.
![Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT | Leukemia Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-022-01803-x/MediaObjects/41375_2022_1803_Fig1_HTML.png)
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT | Leukemia
![Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial - The Lancet Respiratory Medicine Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/b27e4a53-5112-48fc-bca9-de3758d7f8ba/gr1.jpg)
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial - The Lancet Respiratory Medicine
![Altum sequencing – Following the genetic trail of cancer – Altum sequencing is a biomedical company specializing in the identification of patient specific genetic markers suitable for MRD monitoring. Altum sequencing – Following the genetic trail of cancer – Altum sequencing is a biomedical company specializing in the identification of patient specific genetic markers suitable for MRD monitoring.](https://i.ytimg.com/vi/PFcsAWtshnM/maxresdefault.jpg)
Altum sequencing – Following the genetic trail of cancer – Altum sequencing is a biomedical company specializing in the identification of patient specific genetic markers suitable for MRD monitoring.
![Frontiers | The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients Frontiers | The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients](https://www.frontiersin.org/files/Articles/1054458/fonc-12-1054458-HTML/image_m/fonc-12-1054458-g001.jpg)
Frontiers | The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients
![PDF) Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma PDF) Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma](https://i1.rgstatic.net/publication/367161786_Genetic_Alterations_in_Members_of_the_Proteasome_26S_Subunit_AAA-ATPase_PSMC_Gene_Family_in_the_Light_of_Proteasome_Inhibitor_Resistance_in_Multiple_Myeloma/links/63c4305ae922c50e9999df67/largepreview.png)
PDF) Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
![Bradyrhizobium altum sp. nov., Bradyrhizobium oropedii sp. nov. and Bradyrhizobium acaciae sp. nov. from South Africa show locally restricted and pantropical nodA phylogeographic patterns - ScienceDirect Bradyrhizobium altum sp. nov., Bradyrhizobium oropedii sp. nov. and Bradyrhizobium acaciae sp. nov. from South Africa show locally restricted and pantropical nodA phylogeographic patterns - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1055790321002712-ga1.jpg)
Bradyrhizobium altum sp. nov., Bradyrhizobium oropedii sp. nov. and Bradyrhizobium acaciae sp. nov. from South Africa show locally restricted and pantropical nodA phylogeographic patterns - ScienceDirect
![Detection of Emerging Resistant Clones in Philadelphia-Positive Leukemia Patients Exposed to Tyrosine Kinase Inhibitors. Correlation of cDNA and Gdna Approaches - ScienceDirect Detection of Emerging Resistant Clones in Philadelphia-Positive Leukemia Patients Exposed to Tyrosine Kinase Inhibitors. Correlation of cDNA and Gdna Approaches - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497118695722-gr1.jpg)
Detection of Emerging Resistant Clones in Philadelphia-Positive Leukemia Patients Exposed to Tyrosine Kinase Inhibitors. Correlation of cDNA and Gdna Approaches - ScienceDirect
![Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA | Scientific Reports Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-17271-3/MediaObjects/41598_2022_17271_Fig3_HTML.png)